AIM ImmunoTech Inc. — Form 8-K
Filed September 14, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
AIM ImmunoTech agreed to exchange a partitioned promissory note (amount unspecified in blank agreement template) originally issued to Streeterville Capital LLC on November 18, 2025 for an unspecified number of common shares. The original note principal was $3,301,250. The exchange shares will be issued without restrictive legend under Rule 144, with holding period tacking to the original November 2025 note issuance date. Key terms remain incomplete (partitioned note amount and share count are blanks in the template).
Why this rating
Debt-to-equity conversion of substantial amount (~$3.3M or more) relative to $6.4M market cap materially dilutes shareholders and signals financial stress, though exact dilution unknown due to incomplete agreement.
Price action (we called it negative)
before filing · preread $0.22 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.